PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.63%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.29%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-5.86%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.38%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-0.12%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.26%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.02%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
13.02%
Maintaining or increasing dividends while QCOM cut them. John Neff might see a strong edge in shareholder returns.
-8.03%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-10.39%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
70.78%
10Y revenue/share CAGR under 50% of QCOM's 480.28%. Michael Burry would suspect a lasting competitive disadvantage.
29.09%
5Y revenue/share CAGR under 50% of QCOM's 147.44%. Michael Burry would suspect a significant competitive gap or product weakness.
3.75%
3Y revenue/share CAGR under 50% of QCOM's 63.32%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
60.55%
10Y OCF/share CAGR at 50-75% of QCOM's 101.94%. Martin Whitman might fear a structural deficiency in operational efficiency.
50.79%
5Y OCF/share CAGR above 1.5x QCOM's 21.90%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
42.19%
Positive 3Y OCF/share CAGR while QCOM is negative. John Neff might see a big short-term edge in operational efficiency.
177.33%
Below 50% of QCOM's 367.08%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
49.47%
Below 50% of QCOM's 134.89%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
200.49%
3Y net income/share CAGR above 1.5x QCOM's 80.21%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
31.01%
Below 50% of QCOM's 292.66%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
26.82%
Below 50% of QCOM's 91.76%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
2.97%
Below 50% of QCOM's 46.03%. Michael Burry suspects a serious short-term disadvantage in building book value.
1232.73%
10Y dividend/share CAGR above 1.5x QCOM's 494.99%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
183.53%
5Y dividend/share CAGR 1.25-1.5x QCOM's 146.72%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
100.21%
3Y dividend/share CAGR similar to QCOM's 95.39%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-15.64%
Firm’s AR is declining while QCOM shows 15.74%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.88%
Inventory shrinking or stable vs. QCOM's 23.04%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-0.99%
Negative asset growth while QCOM invests at 0.45%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.49%
Under 50% of QCOM's 1.52%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.06%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-6.33%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.34%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.